Bank of New York Mellon
VIGL

Bank of New York Mellon’s Vigil Neuroscience VIGL Stock Holding History

Bank of New York Mellon’s Portfolio VIGL Stock Details VIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-45,750
Closed -$156K – 4269
2024
Q1 		$156K Sell
45,750
-2,738
-6% -$8.55K ﹤0.01% 3982
2023
Q4 		$164K Hold
48,488
– – ﹤0.01% 4004
2023
Q3 		$261K Hold
48,488
– – ﹤0.01% 3868
2023
Q2 		$456K Buy
+48,488
New +$458K ﹤0.01% 3648
2022
Q2 		– Sell
-13,341
Closed -$94K – 4704
2022
Q1 		$94K Buy
+13,341
New +$176K ﹤0.01% 4415

Other funds holding VIGL

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

Bank of New York Mellon's VIGL Position: Q2 2024 in Review

Bank of New York Mellon sold out of Vigil Neuroscience (VIGL) in Q2 2024, closing a stake of 45,750 shares — an estimated $156K sold.

Bank of New York Mellon first reported a position in VIGL in Q1 2022 and held it in 5 quarters. The position peaked at $456K in Q2 2023. 58 funds tracked by Wall St. Rank hold VIGL as of Q2 2024.

  • Bank of New York Mellon reported no remaining Vigil Neuroscience position as of Q2 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 45,750 Vigil Neuroscience shares in Q2 2024, an estimated $156K.
  • Bank of New York Mellon first reported a position in Vigil Neuroscience in Q1 2022 and held it in 5 quarters.
  • Bank of New York Mellon's Vigil Neuroscience position peaked at $456K in Q2 2023.
  • 58 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q2 2024.

Based on Bank of New York Mellon's 13F filing for Q2 2024, filed 25 Jul 2024.